19-39784670-G-A

Variant summary

Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong

The NM_001382345.1(LEUTX):​c.151G>A​(p.Val51Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000458 in 1,551,370 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).

Frequency

Genomes: 𝑓 0.00035 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00047 ( 0 hom. )

Consequence

LEUTX
NM_001382345.1 missense

Scores

1
4
13

Clinical Significance

Uncertain significance criteria provided, multiple submitters, no conflicts U:2

Conservation

PhyloP100: 0.0240
Variant links:
Genes affected
LEUTX (HGNC:31953): (leucine twenty homeobox) Predicted to enable DNA-binding transcription factor activity, RNA polymerase II-specific and RNA polymerase II cis-regulatory region sequence-specific DNA binding activity. Predicted to be involved in regulation of transcription by RNA polymerase II. Predicted to be part of chromatin. Predicted to be active in nucleus. [provided by Alliance of Genome Resources, Apr 2022]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Likely_benign. Variant got -2 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.030838042).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
LEUTXNM_001382345.1 linkuse as main transcriptc.151G>A p.Val51Ile missense_variant 2/3 ENST00000638280.2 NP_001369274.1
LEUTXNM_001143832.2 linkuse as main transcriptc.61G>A p.Val21Ile missense_variant 2/3 NP_001137304.1 A8MZ59-1

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
LEUTXENST00000638280.2 linkuse as main transcriptc.151G>A p.Val51Ile missense_variant 2/33 NM_001382345.1 ENSP00000491740.1 A8MZ59-2
LEUTXENST00000396841.4 linkuse as main transcriptc.61G>A p.Val21Ile missense_variant 2/32 ENSP00000380053.3 A8MZ59-1

Frequencies

GnomAD3 genomes
AF:
0.000348
AC:
53
AN:
152156
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000121
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000589
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000544
Gnomad OTH
AF:
0.000955
GnomAD3 exomes
AF:
0.000371
AC:
58
AN:
156376
Hom.:
0
AF XY:
0.000290
AC XY:
24
AN XY:
82884
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.000730
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.0000917
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000612
Gnomad OTH exome
AF:
0.000457
GnomAD4 exome
AF:
0.000470
AC:
658
AN:
1399096
Hom.:
0
Cov.:
30
AF XY:
0.000452
AC XY:
312
AN XY:
690088
show subpopulations
Gnomad4 AFR exome
AF:
0.000253
Gnomad4 AMR exome
AF:
0.000756
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.0000280
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.0000609
Gnomad4 NFE exome
AF:
0.000546
Gnomad4 OTH exome
AF:
0.000500
GnomAD4 genome
AF:
0.000348
AC:
53
AN:
152274
Hom.:
0
Cov.:
32
AF XY:
0.000309
AC XY:
23
AN XY:
74454
show subpopulations
Gnomad4 AFR
AF:
0.000120
Gnomad4 AMR
AF:
0.000588
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.000544
Gnomad4 OTH
AF:
0.000945
Alfa
AF:
0.000426
Hom.:
0
Bravo
AF:
0.000374
TwinsUK
AF:
0.00108
AC:
4
ALSPAC
AF:
0.000259
AC:
1
ESP6500AA
AF:
0.00
AC:
0
ESP6500EA
AF:
0.000629
AC:
2
ExAC
AF:
0.000249
AC:
6

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsOct 29, 2021The c.61G>A (p.V21I) alteration is located in exon 2 (coding exon 1) of the LEUTX gene. This alteration results from a G to A substitution at nucleotide position 61, causing the valine (V) at amino acid position 21 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
not provided Uncertain:1
Uncertain significance, criteria provided, single submitternot providedBreakthrough Genomics, Breakthrough Genomics-- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.17
BayesDel_addAF
Benign
-0.25
T
BayesDel_noAF
Benign
-0.24
CADD
Benign
12
DANN
Uncertain
0.99
DEOGEN2
Uncertain
0.45
T;.
Eigen
Benign
-0.71
Eigen_PC
Benign
-0.93
FATHMM_MKL
Benign
0.015
N
M_CAP
Benign
0.040
D
MetaRNN
Benign
0.031
T;T
MetaSVM
Uncertain
0.13
D
MutationAssessor
Benign
1.5
L;.
MutationTaster
Benign
1.0
N
PrimateAI
Benign
0.35
T
PROVEAN
Benign
-0.32
N;.
REVEL
Uncertain
0.30
Sift
Benign
0.35
T;.
Sift4G
Pathogenic
0.0
D;.
Polyphen
0.94
P;.
Vest4
0.18
MVP
0.072
ClinPred
0.028
T
GERP RS
-0.53
Varity_R
0.025
gMVP
0.12

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.020
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs117228099; hg19: chr19-40275310; API